Sponsor or institution

Clinical trials and research at Fondazione Italiana Linfomi - ETS

• 16Clinical trials
• 1Country

Newest trials

All recruiting trials (16)

• Glofitamab for mantle cell lymphoma after CAR-T failure

  This phase 2, multicenter, single-arm study tests glofitamab in adults with mantle cell lymphoma who did not respond to or relapsed after CAR-T cell therapy.

  Recruiting Phase 2 Fondazione Italiana Linfomi - ETS · Alessandria and 13 other locations · NCT07453095

• PET-Guided Dose Reduction for Involved-Site Radiotherapy in Early Unfavourable Hodgkin Lymphoma

  This trial tests whether reducing radiotherapy from 30 Gy to 20 Gy is safe for adults with early unfavourable Hodgkin lymphoma who achieve a metabolic complete response after two ABVD cycles.

  Recruiting Phase 3 Fondazione Italiana Linfomi - ETS · Alessandria and 37 other locations · NCT07256158

• Rituximab plus golcadomide as a chemo-free first-line option for older frail diffuse large B‑cell lymphoma patients using a simplified geriatric assessment

  This treatment tests whether combining rituximab and golcadomide can be an effective chemo-free first-line option for older, frail people newly diagnosed with diffuse large B‑cell lymphoma.

  Recruiting at 18 sites Phase 2 Fondazione Italiana Linfomi - ETS · Alessandria, Alessandria and 19 other locations · NCT06835530

• Collecting data on patients with plasmablastic lymphoma

  This study is collecting information from patients with plasmablastic lymphoma to better understand their treatment, outcomes, and the disease itself.

  Recruiting at 14 sites Fondazione Italiana Linfomi - ETS · Aviano, PN and 22 other locations · NCT06781359

• Systemic treatments for cutaneous T‑cell lymphoma

  This project looks at how different systemic treatments are used in adults with cutaneous T‑cell lymphoma to see which approaches are linked to longer disease control in routine care.

  Recruiting at 9 sites Fondazione Italiana Linfomi - ETS · Ancona and 17 other locations · NCT06588868

• How MYC gene changes relate to the tumor immune environment in diffuse large B‑cell and high‑grade B‑cell lymphoma

  This project will see if MYC gene changes and the tumor's immune environment are linked in adults (18–79) who received curative treatment for diffuse large B‑cell or high‑grade B‑cell lymphoma.

  Recruiting at 14 sites Fondazione Italiana Linfomi - ETS · Alessandria and 19 other locations · NCT06588205

• Evaluating sarcopenia in lymphoma patients receiving CAR-T therapy

  This study is trying to see if measuring muscle loss and overall health can help predict how well CAR-T therapy works and what side effects it might cause in adults with B-cell non-Hodgkin lymphoma.

  Recruiting at 20 sites Fondazione Italiana Linfomi - ETS · Alessandria and 20 other locations · NCT06156774

• Evaluating the impact of new monoclonal antibodies in treating B-cell Non-Hodgkin Lymphoma in Italy

  This study is trying to see how well new monoclonal antibodies work for treating B-cell Non-Hodgkin Lymphoma patients in Italy and what side effects they might have.

  Recruiting at 50 sites Fondazione Italiana Linfomi - ETS · Viagrande, Catania and 60 other locations · NCT06008691

• Using Tislelizumab for Patients with Hodgkin Lymphoma Who Can't Have Standard Chemotherapy

  This study is testing if a new treatment called tislelizumab can help older patients with Hodgkin lymphoma who can't take standard chemotherapy feel better and manage their disease safely.

  Recruiting at 10 sites Phase 2 Fondazione Italiana Linfomi - ETS · Alessandria, IT and 11 other locations · NCT05977673

• Healthy Lifestyle Plan for Lymphoma Survivors

  This study is testing whether a special health plan that includes lifestyle changes and nutrition advice can help lymphoma survivors feel better after they've been in remission for a while.

  Recruiting at 34 sites Fondazione Italiana Linfomi - ETS · Ancona, Ancona and 39 other locations · NCT05934084

• Comparing radiotherapy alone versus with Obinutuzumab for early stage follicular lymphoma

  This study is testing if adding Obinutuzumab to radiation therapy helps people with early-stage follicular lymphoma do better than just radiation alone.

  Recruiting at 43 sites Phase 3 Fondazione Italiana Linfomi - ETS · Sassuolo, Modena (MO) and 48 other locations · NCT05929222

• Overview of Primary Cardiac Lymphoma in Italy

  This study looks at patients in Italy with Primary Cardiac Lymphoma to see how they were treated and what their outcomes were, hoping to improve care for this rare condition.

  Recruiting at 11 sites Fondazione Italiana Linfomi - ETS · Bergamo, Bergamo and 12 other locations · NCT05819528

• Evaluating biomarkers in advanced follicular lymphoma treatment

  This study is trying to see if certain genetic changes in patients with advanced follicular lymphoma can help doctors choose the best chemotherapy treatment after they've received immunotherapy.

  Recruiting at 19 sites Fondazione Italiana Linfomi - ETS · Alessandria and 25 other locations · NCT05816850

• Assessing Quality of Life in Elderly Patients with Low Grade Non-Hodgkin Lymphoma

  This study looks at how the quality of life changes for older patients with low-grade non-Hodgkin lymphoma during and after their treatment.

  Recruiting at 20 sites Fondazione Italiana Linfomi - ETS · Alessandria, Alessandria and 20 other locations · NCT05524298

• Evaluating a treatment combining Daratumumab, Bortezomib, and Dexamethasone for Plasmablastic Lymphoma

  This study is testing a new combination treatment of Daratumumab, Bortezomib, and Dexamethasone to see if it helps people with relapsed or hard-to-treat Plasmablastic Lymphoma.

  Recruiting at 14 sites Phase 2 Fondazione Italiana Linfomi - ETS · Ancona, Ancona and 17 other locations · NCT04915248

• Treatment with Prednisone and Vitamin D for Elderly Patients with Lymphoma

  This study is testing if adding Vitamin D to the usual treatment with prednisone helps older patients with lymphoma do better during their cancer treatment.

  Recruiting at 21 sites Phase 3 Fondazione Italiana Linfomi - ETS · Brescia, BS and 48 other locations · NCT04442412

Quick answers

How many clinical trials run by Fondazione Italiana Linfomi - ETS are recruiting right now?

16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Italy. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 3: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →